1. Anxiolytic- and antidepressant-like actions of Urocortin 2 and its fragments in mice.
- Author
-
Bagosi Z, Csabafi K, Balangó B, Pintér D, Szolomájer-Csikós O, Bozsó Z, Tóth G, Telegdy G, and Szabó G
- Subjects
- Animals, Anxiety physiopathology, Depression physiopathology, Disease Models, Animal, Dose-Response Relationship, Drug, Freezing Reaction, Cataleptic drug effects, Injections, Intraventricular, Male, Maze Learning drug effects, Mice, Mice, Inbred C57BL, Peptides therapeutic use, Swimming psychology, Urocortins chemistry, Anti-Anxiety Agents therapeutic use, Antidepressive Agents therapeutic use, Anxiety drug therapy, Depression drug therapy, Urocortins therapeutic use
- Abstract
The aim of the present study was to investigate the potential anxiolytic- and antidepressant-like actions of Urocortin 2 (Ucn2) and its two fragments, Ucn2 (1-21) and Ucn2 (22-38), in mice, in an attempt to identify the biologically active sequence of this 38 amino acid neuropeptide. In this purpose, male C57BL/6 mice were treated intracerebroventricularly (icv) with 0.125, 0.25, 0.5 and 1 µg/2 µl of Ucn2, Ucn2 (1-21) or Ucn2 (22-38). After 30 min, the mice were evaluated in an elevated plus-maze test and a forced swim test for anxiety- and depression-like behavior, respectively. Each test lasted 5 min. Ucn2 at dose of 0.25 µg/2 µl and Ucn2 (1-21) at dose of 0.125 µg/2 µl, but not Ucn2 (22-38), increased significantly the number of entries into and the time spent in the open-arms, without influencing the total number of entries. In parallel, the same doses of Ucn2 and Ucn2 (1-21), but not Ucn2 (22-38), increased significantly the climbing and the swimming activity, while decreasing significantly the time of immobility. In addition, Ucn2 at doses of 0.125 µg/2 µl and 0.5 µg/2 µl decreased significantly the time of immobility, but they did not change the other parameters. The present study demonstrates that Ucn2 exerts anxiolytic- and antidepressant-like effects in C57BL/6 mice, which are mediated by the N-terminal, but not the C-terminal fragment of the peptide. The establishment of the smallest active sequence by further fragmentation of Ucn2 (1-21) may allow the synthesis of new anxiolytic and antidepressant drugs., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF